Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE

被引：0
|
作者：
Javian C. Malcolm
Nadia Falzone
Jennifer E. Gains
Matthew D. Aldridge
David Mirando
Boon Q. Lee
Mark N. Gaze
Katherine A. Vallis
机构：
[1] University of Oxford,Oxford Institute for Radiation Oncology
[2] University College London Hospitals NHS Foundation Trust,Department of Oncology
[3] University College London Hospitals NHS Foundation Trust,Institute of Nuclear Medicine
[4] MIM Software,undefined
来源：
EJNMMI Physics | / 9卷
关键词：
[; Lu]Lu-DOTATATE; Dosimetry; Inter-cyclic changes; Pharmacokinetics; Peptide receptor radionuclide therapy; Neuroblastoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Incorporation Of 177Lu During Care Of 177Lu-PSMA And 177Lu-DOTATATE Therapy Patients
    Happel, C.
    Kranert, W. T.
    Bockisch, B.
    Kratzel, U.
    Baumgarten, J.
    Ngoc, C. Nguyen
    Garayev, E.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S842 - S843
  • [22] Comparison of Model Implementations in SAAM II and MATLAB/SimBiology: a PBPK model for PRRT with [177Lu] Lu-DOTATATE
    Vasic, V.
    Gustafsson, J.
    Yousefzadeh-Nowshahr, E.
    Beer, A.
    Gleisner, K. Sjogreen
    Glatting, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S367 - S367
  • [23] Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
    Mercedes Mitjavila
    Paula Jimenez-Fonseca
    Pilar Belló
    Virginia Pubul
    Juan Carlos Percovich
    Amparo Garcia-Burillo
    Jorge Hernando
    Javier Arbizu
    Emilia Rodeño
    Montserrat Estorch
    Belén Llana
    Maribel Castellón
    Lina García-Cañamaque
    Pablo Gajate
    Maria Carmen Riesco
    Maria Begoña Miguel
    David Balaguer-Muñoz
    Ana Custodio
    Juana María Cano
    Alexandra Repetto
    Pilar Garcia-Alonso
    Maria Angustias Muros
    Jose Luis Vercher-Conejero
    Alberto Carmona-Bayonas
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2486 - 2500
  • [24] Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients
    Tuncer, Onur
    Steinberger, Daniel
    Steiner, Joseph
    Hinojos, Madeleine
    Rhee, Stephanie Y.
    Humphrey, Brad
    Jafari, Farhad
    Cayci, Zuzan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (10) : 1584 - 1590
  • [25] Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
    Mitjavila, Mercedes
    Jimenez-Fonseca, Paula
    Bello, Pilar
    Pubul, Virginia
    Percovich, Juan Carlos
    Garcia-Burillo, Amparo
    Hernando, Jorge
    Arbizu, Javier
    Rodeno, Emilia
    Estorch, Montserrat
    Llana, Belen
    Castellon, Maribel
    Garcia-Canamaque, Lina
    Gajate, Pablo
    Riesco, Maria Carmen
    Miguel, Maria Begona
    Balaguer-Munoz, David
    Custodio, Ana
    Cano, Juana Maria
    Repetto, Alexandra
    Garcia-Alonso, Pilar
    Muros, Maria Angustias
    Vercher-Conejero, Jose Luis
    Carmona-Bayonas, Alberto
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (08) : 2486 - 2500
  • [26] Comparison Between Different Methods of Red Marrow Absorbed Dose Calculation in Treatments with [177Lu] Lu-DOTATATE. Correlation with Whole Body Absorbed Dose
    Monserrat Fuertes, T.
    Daci, L.
    Alvarez Amigo, A.
    Hierro Rivero, A.
    Garcia Balsa, A.
    Montenegro Iglesias, N.
    Blanco Rubio, J.
    Diaz Garcia, A.
    Menendez Garcia, C.
    Peinado Montes, M. A.
    Minguez Gabina, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S808 - S808
  • [27] Discovery of blood transcriptomic markers for response to [177Lu]Lu-DOTATATE in locally advanced or metastatic neuroendocrine neoplasms
    Bae, S.
    Sung, H.
    Choi, H.
    Im, H.
    Suh, M.
    Paeng, J.
    Cheon, G.
    Kang, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S642 - S643
  • [28] Imaging DNA Damage in vivo following [177Lu] Lu-DOTATATE therapy in a model of pancreatic neuroendocrine cancer
    O'Neill, E.
    Kersemans, V.
    Allen, P.
    Terry, S.
    Torres, J. Baguna
    Smart, S.
    Lee, B. Quan
    Falzone, N.
    Vallis, K.
    Konijnenberg, M.
    de Jong, M.
    Nonnekens, J.
    Cornelissen, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S196 - S196
  • [29] Body mass index and prior therapy lines conditioning response to [177Lu]Lu-DOTATATE therapy in neuroendocrine tumours
    Fernandez Fernandez, J.
    Muros de Fuentes, M.
    Trivino Ibanez, E.
    de la Torre Casares, M. Lopez
    Gonzalez Flores, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S570 - S570
  • [30] Absorbed Doses to Kidneys and Tumours for Alpha-Emitter Peptide Receptor Radionuclide Therapies Estimated with [177Lu]Lu-DOTATATE SPECT Images and Biokinetic Models
    Kvassheim, M.
    Blakkisrud, J.
    Revheim, M. E.
    Tulipan, A. J.
    Stokke, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S371 - S371
12345